Form 8-K Valeant Pharmaceuticals For: Sep 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street rises on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Valeant Pharma (VRX) Mentioned Cautiously in Blog
September 28, 2015 11:35 AM EDTValeant Pharma (NYSE: VRX) was mentioned cautiously in a blog post on Seeking Alpha (link).
Valeant Pharma (VRX) Updates on Recent Stock Price Action; Refutes Media Speculation
September 28, 2015 8:06 AM EDTOn September 28, 2015, Valeant Pharma (NYSE: VRX) distributed a letter to its employees relating to recent changes in Valeants stock price.
Dear Colleagues:
A number of you have asked me and other senior members of our management team about the significant drop in our stock price especially over the past 5 trading days. While the entire pharmaceutical and biotech sector has been impacted by market... More
